Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Human Gene Therapy|November 24, 2011
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignanciesPartow Kebriaei, Helen Huls, Bipulendu Jena, et al.
Circulation Research|May 8, 2010
Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of actionJingxiong Wang, Sui Zhang, Brian Rabinovich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2017
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic MalignanciesJuliet N Barker, Joanne Kurtzberg, Karen Ballen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis EraJoseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Neuro-Oncology Advances|November 26, 2020
RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicineBrittany C Parker Kerrigan, Daniel Ledbetter, Matthew Kronowitz, et al.
Blood Advances|April 12, 2024
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignanciesSupawee Saengboon, Stefan Ciurea, Uday Popat, et al.
British Journal of Haematology|February 3, 2023
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapyXin Shelley Wang, Samer A Srour, Tito Mendoza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantationBetul Oran, Piyanuch Kongtim, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic SyndromesHans C Lee, Rima M Saliba, Gabriela Rondon, et al.
Pageof 12